rosuvastatin | CoronaCentral

rosuvastatin [Drug]

Wikidata: Q415159

Published and Preprint Papers

Topics & Article Type(s)

Title

Therapeutics [Research]

A Retrospective Cohort Study Assessing the Impact of Statin Therapy on Hospital Length of Stay and Inpatient Mortality in COVID-19 Patients.

Therapeutics [Research]

Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT Trial).

Health Policy, Long Haul [Research]

The use of prescription drugs and health care services during the 6-month post-COVID-19 period.

Therapeutics [Research]

Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies.

Therapeutics [Research]

Outpatient medications associated with protection from COVID-19 hospitalization.

Therapeutics [Research]

A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor.

Clinical Trials, Therapeutics [Research]

Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.

Therapeutics [Review]

Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy.

Therapeutics [Research]

OPTIMIZATION OF BLOOD PRESSURE CONTROL AND ANGIOPROTECTION WITH FIXED COMBINATION OF LISINOPRIL + AMLODIPINE + ROSUVASTATIN IN PATIENTS AFTER A COVID-19.

Therapeutics [Research]

Repurposing SARS-CoV-2 Main Protease Inhibitors for HIV-1 Protease Inhibition.